Distal radius fracture. Fracture of lower end of radius
Conditions
Interventions
Intervention 1: Intervention group: receiving fracture treatment (reduction and plating) and then administering Cinnopar(250 µg/ml vial, manufactured by Sinagan Pharmaceutical Company), subcutaneous i
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
45 Years to No maximum
Inclusion criteria
Inclusion criteria: Single radial distal fracture with low energy Fractures require close reduction and plastering
Exclusion criteria
Exclusion criteria: Fracture with displacement or need of surgery Fracture occurring with high energy Administration of bone resorption inhibitors such as bisphosphonates for at least 4 weeks History of chemotherapy or radiotherapy History of urinary stones Hypercalcemia more than 10 mg per deciliter or hypercalciuria Advanced liver or kidney disorder Autoimmune diseases Smoking or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical fracture improvement. Timepoint: Every two weeks for 8 weeks. Method of measurement: Based on an orthopedic physician examination, capability to get things, no movement restrictions, no pain.;Radiographic improvement of fracture(Welding). Timepoint: Every two weeks for 8 weeks. Method of measurement: Based on radiological findings, bone formation and cortex stretching. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Ashrafi
Zahedan University of Medical Sciences
Outcome results
None listed